Growth of the metastatic carcinoma cell line H1650, which harbored moderately activated HER1 and HER2 pathways, was inhibited by the irreversible HER1/2 inhibitor BIBW-2292. This evidence concerns the gene ERBB2 and metastatic carcinoma.